Autolus Therapeutics

AUTL

AUTL Autolus Therapeutics NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    AUTL Chart
    See on advanced chart >

    About

    Autolus Therapeutics plc was incorporated in England and Wales on February 2, 2018. The company is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. Using broad suite of proprietary and modular T...
    • Highlight
      A clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      06/22/2018
    • Established Date
      02/02/2018
    • Full-time Employees
      399
    • Address
      The MediaWorks 191 Wood Lane London W12 7FP United Kingdom
    • Tel
      44-20-38296230
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      American Depositary Receipt (Common Stock)
    cache time: 2024-02-23 18:47:16